Access to transplant centers is a key barrier for kidney transplant evaluation and follow-up
care for both the recipient and donor. Potential kidney transplant recipients and living kidney …

Importance Living donor kidney transplant (LDKT) is the ideal treatment for end-stage kidney
disease, but racial disparities in LDKT have increased over the last 2 decades. Recipient …

Abstract Recent Findings Black and Hispanic patients carry higher burden of kidney
disease, yet have lower access to LDKT. Until recently, these differences were thought to be …

Importance It is unclear whether center-level factors are associated with racial equity in
living donor kidney transplant (LDKT). Objective To evaluate center-level factors and racial …

Background Body mass index of living kidney donors has increased substantially.
Determining candidacy for live kidney donation among obese individuals is challenging …

Importance Identifying the mechanisms of structural racism, such as racial and ethnic
segregation, is a crucial first step in addressing the persistent disparities in access to live …

Background. To date, no living donation program has simultaneously addressed the needs
of both transplant candidates and living donors by separating the advocacy role from the …

Background. Living kidney donors have an increased risk of end-stage renal disease, with
hypertension and diabetes as the predominant causes. In this study, we sought to better …

Background The interplay between ethnicity and socioeconomic deprivation for living-donor
kidney transplantation (LDKT) opportunities is unclear. Methods Data for 2040 consecutive …

Living donor kidney transplant (LDKT) is the best treatment for end‐stage kidney disease,
but there are racial disparities in LDKT rates. To study putative mechanisms of these …